ADI’s proprietary platform uses cutting edge protein microarray technology, which allows for thousands or even tens of thousands of parallel assays to detect specific antibodies present in the …
ADI’s proprietary platform uses cutting edge protein microarray technology, which allows for thousands or even tens of thousands of parallel assays to detect specific antibodies present in the biological...